FDA Approves INLEXZO (Gemcitabine Intravesical System), Poised to Transform Treatment of Certain Bladder Cancers Read more
Teva’s Emrusolmin Receives FDA Fast Track Designation for Multiple System Atrophy Treatment Read more
Novartis to Acquire Tourmaline Bio, Boosting Cardiovascular Pipeline with Pacibekitug for ASCVD Treatment Read more
Health Canada Approves Bylvay for Treating Cholestatic Pruritus in Alagille Syndrome Patients Read more
Lilly’s Jaypirca (pirtobrutinib) Shows Significant Progression-Free Survival Benefit in Treatment-Naïve CLL/SLL Read more
Lilly’s Olomorasib Gets FDA Breakthrough Therapy Nod for New Metastatic KRAS G12C Lung Cancer Treatment Read more
Argo Biopharma Secures Multi-Asset License and Option Deals with Novartis for Cardiovascular Drug Candidates Read more